Hims & Hers Health, Inc. (HIMS)
Hims & Hers is a digital health platform that connects people with licensed medical professionals for treatments related to hair loss, skin care, and mental health.
Is Hims & Hers Health, Inc. a good stock for a UK beginner?
The honest version: There's no rating here and nothing for sale. In its favour: Very high gross margins suggest a strong underlying business model. Worth weighing: The company is not yet consistently profitable.
Is this normal for this company?
Each figure against the range this same company has produced recently. Neither end of a range is the good end.
Profit as a share of sales, from the company's own quarterly statements. The range covers the 5 quarters we hold, and the figure shown is its most recent one.
How these ranges are built
Every number here is the company's own reported figure, not a comparison with other companies. The ranges come from this company's own results and its share price. Where it reports in a different currency from the one its shares trade in, the price-to-earnings range is left out rather than mixing the two.
What does Hims & Hers Health, Inc. do?
The company operates an online shop and consultation service that makes it easier to get prescriptions for common personal health concerns delivered straight to your door. The cash rolls in from selling these subscription-based treatments and charging for the virtual doctor visits that facilitate them. Turning their high sales volume into consistent profit is the challenge, as they are currently hovering right around the break-even point.
On our factor screen it looks strongest on growth and value, and weakest on income.
- !Pays no dividend - the whole return rides on the share price
- ✓Growing - revenue up about 38% over the year
- !Carries a lot of debt - roughly 4.8x its equity
- Growth screens high
- Quality screens low
- Income screens low
Does Hims & Hers Health, Inc. pay a dividend?
No - Hims & Hers Health, Inc. doesn't currently pay a dividend, so the whole return would rest on the share price. Plenty of growing companies reinvest their profits instead of paying them out - neither approach is better or worse, they're just different.
Does Hims & Hers Health, Inc. have more cash or more debt?
It holds about $841.05M in cash against about $1.55B of debt - so it has net debt of about $705.19M. Debt is not automatically a problem - it funds growth - but it has to be serviced and repaid, which matters more when profits wobble.
From the latest reported balance sheet. Cash and debt levels change, and some borrowing is normal - this is context, not a judgment.
What do Hims & Hers Health, Inc.'s numbers mean?
How has it performed?
Growth of £1,000, the worst fall, and year by year
Over about 2 years to 2026-09-11. This is the share price only; any dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
How much has Hims & Hers Health, Inc. actually fallen?
Over the last 2 years of daily prices, Hims & Hers Health, Inc. fell as much as −79% from a high to a later low. Falls like this are normal when you own a share.
Past falls are not a forecast - it can fall further, or recover.
How has it done year by year?
Calendar-year total return - the share price with dividends reinvested - from adjusted closing prices. The current year is only part-complete. Past returns are not a guide to the future.
A closer look at the numbers
Ownership, earnings history, where the money goes, and the outlook range
Does the share price tell you if it's cheap or expensive?
Who owns Hims & Hers Health, Inc.?
About 73% of Hims & Hers Health, Inc., or about 73 in every 100 shares, is held by big institutions such as pension and index funds, and company insiders hold about 6%. The rest, roughly 21%, is held by the public and smaller investors.
What this does and doesn't tell you
This is a recent snapshot of the share register, and it moves. We don't read anything into who owns what - a high institutional share is common for any large listed company and is not a signal about it.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
How much money does Hims & Hers Health, Inc. make?
Revenue and profit by quarter, and how much of each sale turns into profit.
When does Hims & Hers Health, Inc. report earnings, and how did recent quarters go?
Hims & Hers Health, Inc. is next scheduled to report on about 2026-11-09 - dates can move, and we don't predict results; this just tells you when to look.
‘Beat’ and ‘missed’ are against what analysts expected, not whether the business is doing well.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-08-10 | $-0.05 | $-0.37 | Missed -640% |
| 2026-05-11 | $0.13 | $-0.19 | Missed -244% |
| 2026-02-23 | $0.19 | $0.22 | Beat +21% |
| 2025-11-03 | $0.23 | $0.28 | Beat +20% |
| 2025-08-04 | $0.23 | $0.29 | Beat +26% |
| 2025-05-05 | $0.23 | $0.28 | Beat +24% |
Across the last 6 quarters here, Hims & Hers Health, Inc. came in ahead of what analysts expected 4 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Where these figures come from
Each quarter a company reports its results against a consensus of analyst forecasts. The figures here are reported versus expected earnings per share from published results; the expectation is that analyst consensus, not our view. Report dates are estimates and can move.
What are the scenarios for Hims & Hers Health, Inc.?
An illustrative range for the year ahead — not a prediction or a price target.
What are the pros, cons and common questions?
The case each way, and the questions people ask
Becoming a dominant household name in digital health
Regulatory changes impacting online prescription models
What are the pros and cons of Hims & Hers Health, Inc.?
A balance check, not a score or verdict.
- Very high gross margins suggest a strong underlying business model
- Convenient digital-first approach appeals to modern consumers
- Subscription model provides a predictable stream of recurring revenue
- The company is not yet consistently profitable
- High beta indicates the share price can be quite a rollercoaster
- Revenue growth: How fast the company's sales grew versus a year ago. has slowed down recently
- Changes in healthcare regulations could disrupt the online prescription process
- Intense competition from both established pharmacies and new digital entrants
- High reliance on marketing spend to acquire new customers
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained shift to consistent net profitability
- A significant change in government rules regarding telehealth prescriptions
Common questions about Hims & Hers Health, Inc.
Does Hims & Hers Health, Inc. pay a dividend?
No - Hims & Hers Health, Inc. does not currently pay a dividend, so the return would rest on the share price. Many growing companies reinvest profits instead of paying them out.
When does Hims & Hers Health, Inc. report earnings next?
Hims & Hers Health, Inc. is next scheduled to report results on about 2026-11-09. Report dates are estimates and can move; this is a diary note for when to look, not a forecast of the outcome.
More in Healthcare
Intellia Therapeutics, Inc.
Novavax, Inc.
Smith & Nephew
Bristol-Myers Squibb Company
Align Technology, Inc.
Craneware plc
Genus plc
PureTech Health plcBuilt from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-02 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.